Press release
Companion Animal Healthcare Market Growth and Future Scope of Key Major Players are Bayer HealthCare Pharmaceuticals LLC, Boehringer Ingelheim, Elanco, Merck & Co., Merial, Virbac, Zoetis
Increasing adoption of companion animals is driving the market. Companion animals are the animals which serve man by giving companionship and guarding their houses or offices. Various types of diseases in animals and their transfer to humans via their product consumption and companionship are escalating the market globally.
Companion Animal Healthcare Market Competitive Landscape Analysis:
The market is very competitive with major players accounting for about three fourth of the market. So, the companies are focusing more on their research and advancement in developmental activities to produce better pharmaceutical and vaccine products for their existing and newly diagnosed diseases. Greater investment in Research and Development to develop drugs would fetch companion animal healthcare companies’ lucrative profits in the coming 15-20 years.
Request for Sample @ https://www.marketdataforecast.com/market-reports/companion-animal-health-care-market-1249/request-sample
Growing incidence of zoonotic and food-borne diseases will be a potential concern for the health of pet animals. In many countries such as the U.S., brucellosis is increasing and causes abortion in animals. Increasing pet/companion ownership, growing health care concerns of pets, rising demand for improved nutrition, are the major factor driving the growth of the market. The factors that are hindering the growth of the market are restrictions by regulatory bodies have a negative impact on the sales of antibiotics, soaring costs and increasing regulations on animal testing have hindered a number of healthcare companies from manufacturing newly advanced drugs.
Companion Animal Healthcare Market Forecast Report (2018-2023):
Global Companion Animal Healthcare Market Value was worth USD $14.36 Billion in 2018 and estimated to reach USD $19.4 Billion by the end of 2023 with a growing potential at a CAGR of 6.20 %.
Companion Animal Healthcare Market Segmentation:
Companion Animal Healthcare Market Segmentation by Product, and further divide into Feed additives, Pharmaceuticals, and vaccines. The feed additives segment is further segmented into Nutritional feed additives and Medicinal feed additives. Nutritional feed additives are given to animals for ensuring their growth. Nutritional feed additives include Proteins, minerals, amino acids, and vitamins. On the other hand, medicinal feed additives target particular types of diseases in companion animals. Medicinal feed additives include enzymes, probiotics, hormones, immune modulators, prebiotics, and feed acidifiers. Pharmaceutical products in the Companion animal healthcare market include ectoparasiticides, endectocides, antibiotics, anti-inflammatories, and medicines for curing reproductive problems. Based on Geography, the Companion Animal healthcare market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America accounts for the largest share of the market due to the growing expenditure on pet nutrition and health care.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/companion-animal-health-care-market-1249/
Key Developments in the Market:
• April 2017 - Zoetis completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody therapies for companion animals in pain and other therapeutic areas
Major Players:
• Bayer HealthCare Pharmaceuticals LLC,
• Boehringer Ingelheim,
• Elanco,
• Merck & Co., Merial,
• Virbac,
• Zoetis
Buy now @ https://www.marketdataforecast.com/cart/buy-now/companion-animal-health-care-market-1249/
Reasons to Purchase Companion Animal Healthcare Market Report:
• Current and future Companion Animal Healthcare Market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet in excel
Customize Report @ https://www.marketdataforecast.com/market-reports/companion-animal-health-care-market-1249/customize-report
About Us:
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Animal Healthcare Market Growth and Future Scope of Key Major Players are Bayer HealthCare Pharmaceuticals LLC, Boehringer Ingelheim, Elanco, Merck & Co., Merial, Virbac, Zoetis here
News-ID: 1362189 • Views: …
More Releases from Market Data Forecast
Business Management Consulting Service Market is expected to witness a significa …
According to the latest research report published by Market Data Forecast, the global business management consulting services market is estimated to grow at a CAGR of 4.3% from 2024 to 2029 and be worth USD 1148 bn by 2029 from USD 930.15 bn in 2024.
The demand for consulting services is fuelled by the need for outside help from several enterprises, charitable organizations, and government agencies. Business management consulting advises organizations…
Antimicrobial Coatings Market expected to witness a significant growth rate of 1 …
According to the latest research report published by Market Data Forecast, the global antimicrobial coatings market is expected to grow at a CAGR of 11% during the forecast period 2024-2029. The market value was at USD 5 billion in 2023 and the value is expected to reach USD 9 billion by the end of 2029.
It is applied to stop microorganisms and other bacteria from growing and expanding. These are extensively…
End-User Computing Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the global end-user computing market is predicted to reach USD 15.33 billion in 2024 and USD 27.99 billion in 2029, growing at a CAGR of 12.8% during the forecast period.
Today's workforce is moving, with employees looking to access corporate data, apps, and online resources across more devices and locations. While supporting workplace mobility, minimizing risk, and maintaining compliance, end-user…
Smart Homes Market Size, Share, Growth Report 2024-2029
According to the latest research report published by Market Data Forecast, the global smart home market is predicted to reach USD 114.92 billion in 2024 and USD 221.46 billion by 2029, growing at a CAGR of 14.02% during the forecast period.
Advancements in IoT technology, as well as rising consumer demand for convenience and energy efficiency, are driving significant growth in the smart home industry. Smart thermostats, lighting, security systems, and…
More Releases for Companion
Companion Animal Drugs - Key Market Statistics
Companion animals are pets kept primarily for company, entertainment, and safety. Owners of companion animals consider them to be family, friends, and confidants. Dogs, cats, birds, rabbits, horses, goats, gerbils, rats, mice, and amphibians, others are considered as companion animals.
Read Report Overview - https://www.transparencymarketresearch.com/companion-animal-specialty-drugs-market.html
According to the American Society for the Prevention of Cruelty to Animals (ASPCA) defines companion animal to be domesticated or domestically-bred whose emotional, physical, social, and behavioral…
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S.
Moreover, the…
Companion Diagnostics Market - Easing of Regulatory Policies to Drive Global Dem …
Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting…
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test…
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine
Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.…
Companion diagnostics Market: Companion diagnostic are used to determine patient …
The few companion diagnostics are already available in the market for specific types of cancer and many are already under clinical development. Companion diagnostics test depends on finding a specific biomarker in the patient and hence biomarker presence or absence determines whether or not the patient will respond to the treatment. This test require a biopsied tissue to access the expression of biomarker protein or mutant or aberrant genes. Companion…
